ScholarLens Back to search
2018•Critical Reviews in Oncology/HematologyRequires access

Resistance to EGFR inhibitors in non-small cell lung cancer: Clinical management and future perspectives

Chiara Tomasello, Cinzia Baldessari, Martina Napolitano, Giulia Orsi, Giulia Grizzi, Federica Bertolini, Fausto Barbieri, Stefano Cascinu

Open publisher page 70 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 70 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Lung cancer, Medicine, Resistance (ecology), Acquired resistance, Cancer research, Cancer, Oncology, Intensive care medicine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Resistance to EGFR inhibitors in non-small cell lung cancer: Clinical management and future perspectives — Research Paper | ScholarLens